首页> 外国专利> Method for production of recombinant human factor VIII, recombinant human factor VIII, pharmaceutical product, the use of recombinant human factor VIII, a method for the treatment of diseases related to decreased, inactivation or absence of factor VIII, the use of endoprotease spc6 and / or pace4 Oh, and / or pacesol and proteolytic processing of recombinant human factor VIII.

Method for production of recombinant human factor VIII, recombinant human factor VIII, pharmaceutical product, the use of recombinant human factor VIII, a method for the treatment of diseases related to decreased, inactivation or absence of factor VIII, the use of endoprotease spc6 and / or pace4 Oh, and / or pacesol and proteolytic processing of recombinant human factor VIII.

机译:重组人凝血因子VIII的生产方法,重组人凝血因子VIII,药物产品,重组人凝血因子VIII的使用,治疗与凝血因子VIII降低,失活或不存在有关的疾病的方法,内切蛋白酶spc6和 /或步骤4,和/或步骤溶胶和重组人因子VIII的蛋白水解处理。

摘要

Summary method for production of recombinant human factor VIII to the present invention has for object methods for the production of recombinant human factor VIII, which employ specific Endoproteases, ensuring the complete proteolytic processing of this factor during its biosynthesis. Consequently, avoiding the additional steps of purification.Objects of the present invention is recombinant human factor VIII obtained by such methods, pharmaceutical compositions, uses and methods of treatment related.
机译:本发明生产重组人因子VIII的概述方法的目标方法是生产重组人因子VIII的方法,其使用特定的内切蛋白酶,确保该因子在其生物合成过程中的完全蛋白水解过程。因此,避免了额外的纯化步骤。本发明的目的是通过这种方法,药物组合物,用途和相关治疗方法获得的重组人因子VIII。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号